- Email: [email protected]
Novartis LA
A strong start for a successful day! ®
Ritalin LA — Helping children with ADHD reach for their full potential Data confirmed in 2 clinical trials 1,2
• Ritalin LA® 20 mg demonstrated superior improvement in attention vs Concerta® C (methylphenidate HCI) extended-release tablets 36 mg over the first 4 hours • Improvement in math test scores* • Improvement in attention throughout the school day Ask your Novartis sales representative for more information.
Ritalin LA® should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence. Frank psychotic episodes can occur, especially with parenteral abuse. (See Boxed Warning.) Data are from 2 head-to-head, placebo-controlled, crossover, analog-classroom studies of 36 and 54 patients. *Improvement in score should be attributed to an improvement in attention and concentration.
Ritalin LA® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Please see brief summary of full prescribing information, including Contraindications and Boxed Warning, provided on the following page. References: 1. Data on file. Novartis Pharmaceuticals Corporation. 2. Lopez F, Silva R, Pestreich L, Muniz R. Comparative efficacy of two once-daily methylphenidate formulations (Ritalin LA® and Concerta®) and placebo in children with attention deficit hyperactivity disorder across the school day. Pediatr Drugs. 2003;5:545-555. Concerta is a registered trademark of McNeil Consumer and Specialty Pharmaceuticals.
10 mg, 20 mg, 30 mg, 40 mg
The ADHD Original.Optimized.
Ritalin LA — Helping children with ADHD reach for their full potential Data confirmed in 2 clinical trials 1,2
• Ritalin LA® 20 mg demonstrated superior improvement in attention vs Concerta® C (methylphenidate HCI) extended-release tablets 36 mg over the first 4 hours • Improvement in math test scores* • Improvement in attention throughout the school day Ask your Novartis sales representative for more information.
Ritalin LA® should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence. Frank psychotic episodes can occur, especially with parenteral abuse. (See Boxed Warning.) Data are from 2 head-to-head, placebo-controlled, crossover, analog-classroom studies of 36 and 54 patients. *Improvement in score should be attributed to an improvement in attention and concentration.
Ritalin LA® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Please see brief summary of full prescribing information, including Contraindications and Boxed Warning, provided on the following page. References: 1. Data on file. Novartis Pharmaceuticals Corporation. 2. Lopez F, Silva R, Pestreich L, Muniz R. Comparative efficacy of two once-daily methylphenidate formulations (Ritalin LA® and Concerta®) and placebo in children with attention deficit hyperactivity disorder across the school day. Pediatr Drugs. 2003;5:545-555. Concerta is a registered trademark of McNeil Consumer and Specialty Pharmaceuticals.
10 mg, 20 mg, 30 mg, 40 mg
The ADHD Original.Optimized.